COMP <GO>
NVCT vs ZVRA // PIOTROSKI F-SCORE QUALITY
Nuvectis Pharma Inc. (NASDAQ) VS. Zevra Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: NVCT 0
— ZVRA 5
▲ PIOTROSKI F-SCORE QUALITY LEADER: ZVRA
LAST: $18.57 (+1.14%) • MKT CAP: $605.6M
piotroski-score
2/9
LAST: $10.36 (+0.49%) • MKT CAP: $615.2M
piotroski-score
4/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVCT VS. ZVRA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVCT | ZVRA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -32.30% | -2.70 | ZVRA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.64% | -0.40% | -2.24 | ZVRA | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 2/9 | 4/9 | -2.00 | ZVRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 42.0 | 47.0 | -5.00 | ZVRA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 6.9x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $605.6M | $615.2M | -$9.6M | ZVRA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVCT REV | ZVRA REV | NVCT GROSS % | ZVRA GROSS % | NVCT FCF | ZVRA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$16.0M | -$2.4M |
| FY 2024 | $0 | $0 | — | — | -$12.2M | -$69.7M |
| FY 2023 | $0 | $0 | — | — | -$16.0M | -$33.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVCT // BETA —
ZVRA // BETA —